Dr Uta Griesenbach

Publications


Journals

  • Kernan NG; Alton EW; Cullinan P; Griesenbach U; Bilton D. (3 May 2012). Oral contraceptives do not appear to affect cystic fibrosis disease severity. Eur Respir J. DOI.
  • Griesenbach U; Alton EW. (2012). Progress in gene and cell therapy for cystic fibrosis lung disease. Curr Pharm Des. 18:642-662.
  • McLachlan G; Davidson H; Holder E; Davies LA; Pringle IA; Sumner-Jones SG; Baker A; Tennant P; et alGordon C; Vrettou C; Blundell R; Hyndman L; Stevenson B; Wilson A; Doherty A; Shaw DJ; Coles RL; Painter H; Cheng SH; Scheule RK; Davies JC; Innes JA; Hyde SC; Griesenbach U; Alton EW; Boyd AC; Porteous DJ; Gill DR; Collie DD. (Oct 2011). Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung. Gene Ther. 18:996-1005. DOI.
  • Griesenbach U; McLachlan G; Collie D; Innes J; Higgins T; Cheng S; Scheule R; Alton EW; et alDavies JC; Hyde SC; Porteous D; Boyd AC. (1 Jan 2011). TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL. PEDIATRIC PULMONOLOGY. 298-298. Author weblink.
  • Davies JC; Davies G; Gill D; Hyde S; Boyd C; Innes JA; Porteous D; Cheng S; et alScheule R; Higgins T; Griesenbach U; Alton EW. (1 Jan 2011). SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF. PEDIATRIC PULMONOLOGY. 281-281. Author weblink.
  • McLachlan G; Davidson H; Holder E; Davies LA; Pringle IA; Sumner-Jones SG; Baker A; Tennant P; et alGordon C; Vrettou C; Blundell R; Hyndman L; Stevenson B; Wilson A; Doherty A; Shaw DJ; Coles RL; Painter H; Cheng SH; Sheule RK; Davies JC; Innes JA; Hyde SC; Griesenbach U; Alton EW; Boyd AC; Proteous DJ; Gill DR; Collie DD. (2011). Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung. Gene Therapy (Basingstoke). DOI.
  • Griesenbach U; Alton EW. (1 Apr 2011). Current status and future directions of gene and cell therapy for cystic fibrosis. BioDrugs. 25:77-88. DOI.
  • Griesenbach U; Soussi S; Newman N; Donovan J; Leiton J; Campbell K; Gibson J. (1 Jan 2010). INFLAMMATORY MARKERS: DATA FROM THE UK CF GENE THERAPY CONSORTIUM RUN-IN STUDY. PEDIATRIC PULMONOLOGY. 360-361.
  • Gill DR; Pringle IA; Lawton AE; Connolly MM; Sumner-Jones SG; Davies LA; Meng C; Griesenbach U; et alHyde SC. (1 Jan 2010). DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY. PEDIATRIC PULMONOLOGY. 315-315.
  • Singh C; Munkonge F; Smith S; Griesenbach U; Carzaniga R; Pape T; Cheng S; Rogers A; et alDewar A; Alton EW. (1 Jan 2010). QUANTITATIVE BIOLOGICAL IMAGING OF PLASMID DNA IN LIVE HUMAN AIRWAY EPITHELIAL CELLS FOLLOWING NON-VIRAL GENE TRANSFER. PEDIATRIC PULMONOLOGY. 313-313.
  • Griesenbach U; Wilson KM; Farley R; Meng C; Scheule RK; Cheng SH; Alton EW. (1 Jan 2010). ASSESSMENT OF THE NUCLEAR PORE DILATING AGENT TCHD IN DIFFERENTIATED AIRWAY EPITHELIUM. PEDIATRIC PULMONOLOGY. 304-305.
  • Griesenbach U; Inoue M; Meng C; Brum AM; Farley R; Newman N; Akiba E; Hasegawa M; et alAlton EW. (1 Jan 2010). SIV VECTOR PSEUDOTYPED WITH SEV-F/HN ENVELOPE PROTEINS PRODUCES LONG LASTING EXPRESSION IN THE MURINE LUNG, IS READMINISTRABLE & TRANSFECTS HUMAN AIRWAY MODELS. PEDIATRIC PULMONOLOGY. 304-304.
  • Alton EW; Boyd C; Cunningham S; Davies JC; Hyde SC; Innes JA; Gill DR; Greening A; et alGriesenbach U; Higgins T; Porteous DJ. (1 Jan 2010). LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS; THE RUN-IN STUDY. PEDIATRIC PULMONOLOGY. 298-298.
  • Kernan NG; Cullinan P; Alton EW; Bilton D; Griesenbach U. (1 Jan 2010). ORAL CONTRACEPTIVE USE DOES NOT AFFECT CF DISEASE SEVERITY. PEDIATRIC PULMONOLOGY. 250-250.
  • Griesenbach U; Vicente CC; Roberts MJ; Meng C; Soussi S; Xenariou S; Tennant P; Baker A; et alBaker E; Gordon C; Vrettou C; McCormick D; Coles R; Green AM; Lawton AE; Sumner-Jones SG; Cheng SH; Scheule RK; Hyde SC; Gill DR; Collie DD; McLachlan G; Alton EW. (Apr 2011). Secreted Gaussia luciferase as a sensitive reporter gene for in vivo and ex vivo studies of airway gene transfer. Biomaterials. 32:2614-2624. DOI.
  • Griesenbach U; McLachlan G; Owaki T; Somerton L; Shu T; Baker A; Tennant P; Gordon C; et alVrettou C; Baker E; Collie DD; Hasegawa M; Alton EW. (Feb 2011). Validation of recombinant Sendai virus in a non-natural host model. Gene Ther. 18:182-188. DOI.
  • Mitomo K; Griesenbach U; Inoue M; Somerton L; Meng C; Akiba E; Tabata T; Ueda Y; et alFrankel GM; Farley R; Singh C; Chan M; Munkonge F; Brum A; Xenariou S; Escudero-Garcia S; Hasegawa M; Alton EW. (Jun 2010). Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes. Mol Ther. 18:1173-1182. DOI.
  • Griesenbach U; Alton EW. (Aug 2009). Cystic fibrosis gene therapy: successes, failures and hopes for the future. Expert Rev Respir Med. 3:363-371. DOI.
  • Griesenbach U; Soussi S; Larsen MB; Casamayor I; Dewar A; Regamey N; Bush A; Shah PL; et alDavies JC; Alton EW. (Mar 2011). Quantification of periciliary fluid height in human airway biopsies is feasible, but not suitable as a biomarker. Am J Respir Cell Mol Biol. 44:309-315. DOI.
  • Holder E; Stevenson B; Farley R; Hilliard T; Wodehouse T; Somerton L; Larsen M; O'Donoghue J; et alColes RL; Scheule RK; Cheng SH; Gill DR; Hyde SC; Griesenbach U; Alton EWFW; Porteous DJ; Boyd AC. (1 Jan 2010). Detection of CFTR transgene mRNA expression in respiratory epithelium isolated from the murine nasal cavity. JOURNAL OF GENE MEDICINE. 12:55-63. DOI.
  • Xenariou S; Liang H-D; Griesenbach U; Zhu J; Farley R; Somerton L; Singh C; Jeffery PK; et alScheule RK; Cheng SH; Geddes DM; Blomley M; Alton EWFW. (1 Jan 2010). Low-frequency ultrasound increases non-viral gene transfer to the mouse lung. ACTA BIOCHIMICA ET BIOPHYSICA SINICA. 42:45-51. Author weblink DOI.
  • Davies JC; Gill D; Griesenbach U; Voase N; Davies G; Higgins T; Innes JA; Boyd C; et alPorteous D; Hyde S; Alton EW. (1 Jan 2009). EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY". PEDIATRIC PULMONOLOGY. 305-306. Author weblink.
  • Griesenbach U; Meng C; Farley R; Wasowicz MY; Munkonge FM; Chan M; Stoneham C; Sumner-Jones SG; et alPringle IA; Gill DR; Hyde SC; Stevenson B; Holder E; Ban H; Hasegawa M; Cheng SH; Scheule RK; Sinn PL; McCray PB; Alton EW. (Mar 2010). The use of carboxymethylcellulose gel to increase non-viral gene transfer in mouse airways. Biomaterials. 31:2665-2672. DOI.
  • Davidson H; Wilson A; Gray RD; Horsley A; Pringle IA; McLachlan G; Nairn AC; Stearns C; et alGibson J; Holder E; Jones L; Doherty A; Coles R; Sumner-Jones SG; Wasowicz M; Manvell M; Griesenbach U; Hyde SC; Gill DR; Davies J; Collie DDS; Alton EWFW; Porteous DJ; Boyd AC. (1 Dec 2009). An immunocytochemical assay to detect human CFTR expression following gene transfer. MOLECULAR AND CELLULAR PROBES. 23:272-280. Author weblink DOI.
  • Munkonge FM; Amin V; Hyde SC; Green A-M; Pringle IA; Gill DR; Smith JWS; Hooley RP; et alXenariou S; Ward MA; Leeds N; Leung K-Y; Chan M; Hillery E; Geddes DM; Griesenbach U; Postel EH; Dean DA; Dunn MJ; Alton EWFW. (25 Sep 2009). Identification and Functional Characterization of Cytoplasmic Determinants of Plasmid DNA Nuclear Import. JOURNAL OF BIOLOGICAL CHEMISTRY. 284:26978-26987. Author weblink DOI.
  • Griesenbach U; Sumner-Jones SG; Holder E; Munkonge FM; Wodehouse T; Smith SN; Wasowicz MY; Pringle I; et alCasamayor I; Chan M; Coles R; Cornish N; Dewar A; Doherty A; Farley R; Green AM; Jones BL; Larsen MD; Lawton AE; Manvell M; Painter H; Singh C; Somerton L; Stevenson B; Varathalingam A; Siegel C; Scheule RK; Cheng SH; Davies JC; Porteous DJ; Gill DR; Boyd AC; Hyde SC; Alton EW. (Jul 2010). Limitations of the murine nose in the development of nonviral airway gene transfer. Am J Respir Cell Mol Biol. 43:46-54. DOI.
  • Griesenbach U; Alton EWFW. (27 Feb 2009). Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy. ADVANCED DRUG DELIVERY REVIEWS. 61:128-139. Author weblink DOI.
  • Griesenbach U; Meng C; Farley R; Gardner A; Brake MA; Frankel GM; Gruenert DC; Cheng SH; et alScheule RK; Alton EW. (Apr 2009). The role of doxorubicin in non-viral gene transfer in the lung. Biomaterials. 30:1971-1977. DOI.
  • Griesenbach U; Smith SN; Farley R; Singh C; Alton EWFW. (1 Oct 2008). Validation of nasal potential difference measurements in gut-corrected CF knockout mice. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY. 39:490-496. Author weblink DOI.
  • McBain SC; Griesenbach U; Xenariou S; Keramane A; Batich CD; Alton EWFW; Dobson J. (8 Oct 2008). Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays. NANOTECHNOLOGY. 19. Author weblink DOI.
  • Griesenbach U; Munkonge FM; Sumner-Jones S; Holder E; Smith SN; Boyd AC; Gill DR; Hyde SC; et alPorteous D; Alton EW; UK Cystic Fibrosis Gene Therapy Consortium. (2008). Assessment of CFTR function after gene transfer in vitro and in vivo. Methods Mol Biol. 433:229-242. DOI.
  • Larsen MD; Griesenbach U; Goussard S; Gruenert DC; Geddes DM; Scheule RK; Cheng SH; Courvalin P; et alGrillot-Courvalin C; Alton EW. (Mar 2008). Bactofection of lung epithelial cells in vitro and in vivo using a genetically modified Escherichia coli. Gene Ther. 15:434-442. DOI.
  • Rakonczay Z; Hegyi P; Hasegawa M; Inoue M; You J; Iida A; Ignath I; Alton EWFW; et alGriesenbach U; Ovari G; Vag J; Da Paula AC; Crawford RM; Varga G; Amaral MD; Mehta A; Lonovics J; Argent BE; Gray MA. (1 Feb 2008). CFTR gene transfer to human cystic fibrosis pancreatic duct cells using a sendai virus vector. JOURNAL OF CELLULAR PHYSIOLOGY. 214:442-455. Author weblink DOI.
  • Hilliard TN; Zhu J; Farley R; Escudero-Garcia S; Wainwright BJ; Jeffery PK; Griesenbach U; Bush A; et alDavies JC; Alton EW. (Jul 2008). Nasal abnormalities in cystic fibrosis mice independent of infection and inflammation. Am J Respir Cell Mol Biol. 39:19-25. DOI.
  • Gray RD; Horsley A; Macleod K; Imrie M; Dewar M; Voase N; Donovan J; Hyde S; et alGill D; Griesenbach U; Davies JC; Alton E; Boyd AC; Porteous D; Cunningham S; Innes JA; Greening AP. (1 Jan 2007). UKCF gene therapy consortium tracking study: Sputum and serum calprotectin are useful novel measurements in CF exacerbation. PEDIATRIC PULMONOLOGY. 338-338. Author weblink.
  • Mitomo K; Griesenbach U; Inoue M; Washizawa K; Fujikawa S; Iwasaki H; Somerton L; Farley R; et alSingh C; Hasegawa M; Alton EW. (1 Jan 2007). Potential airway stem/progenitor cell integration after transduction with a lentiviral vector pseudotyped with sendai virus envelope proteins. PEDIATRIC PULMONOLOGY. 286-286.
  • Griesenbach U; Jeswiet SB; Larsen MD; Bakar Y; Voase NW; Gammie F; Gray RD; Horsley A; et alImrie M; Dewar M; Marriott C; Geddes DM; Davies JC; Alton EW. (1 Jan 2007). UKCF gene therapy consortium tracking study: Change in sputum properties in response to IV antibiotic. PEDIATRIC PULMONOLOGY. 229-229. Author weblink.
  • Ban H; Inoue M; Griesenbach U; Munkonge F; Chan M; Iida A; Alton E; Hasegawa M. (1 Dec 2007). Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein. GENE THERAPY. 14:1688-1694. Author weblink DOI.
  • Griesenbach U; Meng C; Farley R; Cheng SH; Scheule RK; Davies MH; Wolstenholme-Hogg PC; ten Hove W; et alvan der Hoeven P; Sinn PL; McCray PB; Inoue M; Geddes DM; Hasegawa M; Frankel G; Wiles S; Alton EW. (Apr 2008). In vivo imaging of gene transfer to the respiratory tract. Biomaterials. 29:1533-1540. DOI.
  • Davies J; Alton E; Griesenbach U. Cystic fibrosis modifier genes. J ROY SOC MED. 98:47-54.
  • Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; et alYou J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW. (Oct 2007). Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther. 14:1371-1379. DOI.
  • McLachlan G; Baker A; Tennant P; Gordon C; Vrettou C; Renwick L; Blundell R; Cheng SH; et alScheule RK; Davies L; Painter H; Coles RL; Lawton AE; Marriott C; Gill DR; Hyde SC; Griesenbach U; Alton EWFW; Boyd AC; Porteous DJ; Collie DDS. (1 Feb 2007). Optimizing aerosol gene delivery and expression in the ovine lung. MOLECULAR THERAPY. 15:348-354. Author weblink DOI.
  • Xenariou S; Griesenbach U; Liang HD; Zhu J; Farley R; Somerton L; Singh C; Jeffery PK; et alFerrari S; Scheule RK; Cheng SH; Geddes DM; Blomley M; Alton EW. (May 2007). Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther. 14:768-774. DOI.
  • Rakonczay Z; Hegyi P; Hasegawa M; Inoue M; You J; Iida A; Ignath I; Alton EWFW; et alGriesenbach U; Ovari G; Da Paula AC; Varga G; Amaral MD; Argent BE; Gray MA. (1 Nov 2006). CFTR gene transfer to human cystic fibrosis pancreatic duct cells upregulates apical CL-/HCO3(-) exchange activity. PANCREAS. 33:492-492. Author weblink DOI.
  • Griesenbach U; Geddes DM; Alton EW. (Jul 2006). Gene therapy progress and prospects: cystic fibrosis. Gene Ther. 13:1061-1067. DOI.
  • Holder E; Griesenbach U; Li S; Huang L; Rogers DF; Jeffery PK; Geddes DM; Alton EW. (Dec 2006). Intravenously administered oligonucleotides can be delivered to conducting airway epithelium via the bronchial circulation. Gene Ther. 13:1628-1638. DOI.
  • Xenariou S; Griesenbach U; Ferrari S; Dean P; Scheule RK; Cheng SH; Geddes DM; Plank C; et alAlton EW. (Nov 2006). Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther. 13:1545-1552. DOI.
  • Griesenbach U; Kitson C; Garcia SE; Farley R; Singh C; Somerton L; Painter H; Smith RL; et alGill DR; Hyde SC; Chow YH; Hu J; Gray M; Edbrooke M; Ogilvie V; MacGregor G; Scheule RK; Cheng SH; Caplen NJ; Alton EWFW. (15 Feb 2006). Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo. RESPIRATORY RESEARCH. 7. Author weblink DOI.
  • Munkonge FM; Hillery E; Griesenbach U; Alton EWFW. (1 Nov 1998). Isolation of a putative nuclear import DNA shuttle protein. MOLECULAR BIOLOGY OF THE CELL. 9:187A-187A. Author weblink.
  • Griesenbach U; Geddes DM; Alton EWFW. (1 Aug 1999). The pathogenic consequences of a single mutated CFTR gene. THORAX. 54:S19-S23. Author weblink.
  • Griesenbach U; Judd D; Ferrari S; Hou X; Fukumura M; Geddes D; Hasegawa M; Alton E. (1 Dec 2000). Sendai virus-mediated overexpression of interleukin 10 following pulmonary and intramuscular adminstration. THORAX. 55:A5-A5. Author weblink.
  • Griesenbach U; Cassady RL; Ferrari S; Fukumura M; Geddes DM; Hasegawa M; Alton EWFW. (1 Dec 2001). A novel approach to the production of serum proteins using recombinant Sendai virus. THORAX. 56:45-45. Author weblink.
  • Griesenbach U; Cassady RL; Cain RJ; Geddes DM; Alton EWFW. (1 Dec 2001). The effect of NFkB decoy oligonucleotides in two murine models of pulmonary inflammation. THORAX. 56:45-45. Author weblink.
  • Griesenbach U; Kren BT; Stern M; Cassady RL; Hllery E; Farley R; Geddes DM; Steer CJ; et alAlton EWFW. (1 Dec 2001). Conversion of wild-type CFTR to the G551D mutation in primary rat hepatocytes using RNA/DNA oligonucleotides. THORAX. 56:44-45. Author weblink.
  • Fox E; Griesenbach U; Rogers DF; Huang L; Li S; Booy B; Jeffery PK; Geddes DM; et alAlton EWFW. (1 Dec 2001). Successful oligodeoxynucleotide transfer to the airway epithelium following intravenous delivery. THORAX. 56:2-2. Author weblink.
  • Degabriele NM; Griesenbach U; Sato K; Zhu J; Williams J; Jeffery PK; Geddes DM; Post MJ; et alAlton EWFW. (1 Aug 2002). Detailed functional and histologic characterisation of the murine myocardial infarction model. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. 29:A81-A82. Author weblink.
  • Griesenbach U; Boyton RJ; Somerton L; Garcia SE; Ferrari S; Owaki T; Ya-Fen Z; Geddes DM; et alHasegawa M; Altmann DM; Alton EW. (Mar 2006). Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung. Gene Ther. 13:449-456. DOI.
  • Judd DV; Griesenbach U; Wells DJ; Geddes DM; Alton EWFW. (1 Dec 1999). Intramuscular gene transfer of interleukin-10 cDNA: Towards treatment for lung inflammation. THORAX. 54:A3-A3. Author weblink.
  • Griesenbach U; Boyd AC; UK Cystic Fibrosis Gene Therapy Consortium. (May 2005). Pre-clinical and clinical endpoint assays for cystic fibrosis gene therapy. J Cyst Fibros. 4:89-100. DOI.
  • Griesenbach U; Inoue M; Hasegawa M; Alton EW. (Aug 2005). Sendai virus for gene therapy and vaccination. Curr Opin Mol Ther. 7:346-352.
  • Radke PW; Griesenbach U; Kivela A; Vick T; Judd D; Munkonge F; Willis S; Geddes DM; et alYla-Herttuala S; Alton EW. (Jun 2005). Vascular oligonucleotide transfer facilitated by a polymer-coated stent. Hum Gene Ther. 16:734-740. DOI.
  • Davies JC; Griesenbach U; Alton E. (May 2005). Modifier genes in cystic fibrosis. Pediatr Pulmonol. 39:383-391. DOI.
  • Ferrari S; Griesenbach U; Shiraki-Iida T; Shu T; Hironaka T; Hou X; Williams J; Zhu J; et alJeffery PK; Geddes DM; Hasegawa M; Alton EW. (Nov 2004). A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Ther. 11:1659-1664. DOI.
  • Griesenbach U; Geddes DM; Alton EW. (Nov 2004). Advances in cystic fibrosis gene therapy. Curr Opin Pulm Med. 10:542-546.
  • Griesenbach U; Geddes DM; Alton EW. (Oct 2004). Gene therapy for cystic fibrosis: an example for lung gene therapy. Gene Ther. 11 Suppl 1:S43-S50. DOI.
  • Radke PW; Heinl-Green A; Frass OM; Griesenbach U; Ferrari S; Geddes DM; Alton EW. (Aug 2004). Effects of intramyocardial pVEGF165 delivery on regional myocardial blood flow: evidence for a spatial 'delivery-efficacy' mismatch. Gene Ther. 11:1249-1255. DOI.
  • Degabriele NM; Griesenbach U; Sato K; Post MJ; Zhu J; Williams J; Jeffery PK; Geddes DM; et alAlton EW. (Jul 2004). Critical appraisal of the mouse model of myocardial infarction. Exp Physiol. 89:497-505. DOI.
  • Emerson M; Renwick L; Tate S; Rhind S; Milne E; Painter HA; Boyd AC; McLachlan G; et alGriesenbach U; Cheng SH; Gill DR; Hyde SC; Baker A; Alton EW; Porteous DJ; Collie DD. (Oct 2003). Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments. Mol Ther. 8:646-653.
  • Griesenbach U; Geddes DM; Alton EW. (Oct 2003). Update on gene therapy for cystic fibrosis. Curr Opin Mol Ther. 5:489-494.
  • Munkonge FM; Dean DA; Hillery E; Griesenbach U; Alton EW. (16 Jun 2003). Emerging significance of plasmid DNA nuclear import in gene therapy. Adv Drug Deliv Rev. 55:749-760.
  • Ferrari S; Griesenbach U; Geddes DM; Alton E. (Apr 2003). Immunological hurdles to lung gene therapy. Clin Exp Immunol. 132:1-8.
  • Griesenbach U; Ferrari S; Geddes DM; Alton EW. (Oct 2002). Gene therapy progress and prospects: cystic fibrosis. Gene Ther. 9:1344-1350. DOI.
  • Griesenbach U; Cassady RL; Cain RJ; duBois RM; Geddes DM; Alton EW. (Aug 2002). Cytoplasmic deposition of NFkappaB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation. Gene Ther. 9:1109-1115. DOI.
  • Griesenbach U; Cassady RL; Ferrari S; Fukumura M; Müller C; Schmitt E; Zhu J; Jeffery PK; et alNagai Y; Geddes DM; Hasegawa M; Alton EW. (Feb 2002). The nasal epithelium as a factory for systemic protein delivery. Mol Ther. 5:98-103. DOI.
  • Griesenbach U; Alton EW. (Aug 2001). Recent progress in gene therapy for cystic fibrosis. Curr Opin Mol Ther. 3:385-389.
  • Scheid P; Kempster L; Griesenbach U; Davies JC; Dewar A; Weber PP; Colledge WH; Evans MJ; et alGeddes DM; Alton EW. (Jan 2001). Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. Eur Respir J. 17:27-35.
  • Yonemitsu Y; Kitson C; Ferrari S; Farley R; Griesenbach U; Judd D; Steel R; Scheid P; et alZhu J; Jeffery PK; Kato A; Hasan MK; Nagai Y; Masaki I; Fukumura M; Hasegawa M; Geddes DM; Alton EW. (Sep 2000). Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol. 18:970-973. DOI.
  • Stern M; Ulrich K; Robinson C; Copeland J; Griesenbach U; Masse C; Cheng S; Munkonge F; et alGeddes D; Berthiaume Y; Alton E. (Jun 2000). Pretreatment with cationic lipid-mediated transfer of the Na+K+-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedema. Gene Ther. 7:960-966. DOI.
  • Griesenbach U; Scheid P; Hillery E; de Martin R; Huang L; Geddes DM; Alton EW. (Feb 2000). Anti-inflammatory gene therapy directed at the airway epithelium. Gene Ther. 7:306-313. DOI.
  • Alton EW; Griesenbach U; Geddes DM. (Feb 1999). Gene therapy for asthma: inspired research or unnecessary effort?. Gene Ther. 6:155-156. DOI.
  • Alton EW; Griesenbach U; Geddes DM. (Oct 1998). Milking gene therapy. Nat Med. 4:1121-1122. DOI.
  • Gosselin D; Stevenson MM; Cowley EA; Griesenbach U; Eidelman DH; Boulé M; Tam MF; Kent G; et alSkamene E; Tsui LC; Radzioch D. (Apr 1998). Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa. Am J Respir Crit Care Med. 157:1253-1262.
  • Griesenbach U; Chonn A; Cassady R; Hannam V; Ackerley C; Post M; Tanswell AK; Olek K; et alO'Brodovich H; Tsui L-C. (Feb 1998). Comparison between intratracheal and intravenous administration of liposome-DNA complexes for cystic fibrosis lung gene therapy. Gene Ther. 5:181-188. DOI.
  • Stern M; Caplen NJ; Browning JE; Griesenbach U; Sorgi F; Huang L; Gruenert DC; Marriot C; et alCrystal RG; Geddes DM; Alton EW. (Jan 1998). The effect of mucolytic agents on gene transfer across a CF sputum barrier in vitro. Gene Ther. 5:91-98. DOI.
  • Kent G; Iles R; Bear CE; Huan LJ; Griesenbach U; McKerlie C; Frndova H; Ackerley C; et alGosselin D; Radzioch D; O'Brodovich H; Tsui LC; Buchwald M; Tanswell AK. (15 Dec 1997). Lung disease in mice with cystic fibrosis. J Clin Invest. 100:3060-3069. DOI.
  • Baumstark-Khan C; Griesenbach U; Rink H. (1992). Comparison of DNA strand break induction in CHO cells measured by alkaline elution and by fluorometric analysis of DNA unwinding (FADU). Free Radic Res Commun. 16:381-389.

Conferences

  • Ng-Blichfeldt JP; Griffiths M; Griesenbach U; Allen B; Hind M. THE ROLE OF THE RETINOIC ACID PATHWAY IN HUMAN LUNG REGENERATION. Winter Meeting of the British-Thoracic-Society, 7 Dec 2011 - 9 Dec 2011. 66:A115-A115. B M J PUBLISHING GROUP (1 Dec 2011). DOI.
  • Davies G; Davies JC; Gill DR; Hyde SC; Boyd C; Innes JA; Porteous DJ; Cheng SH; et alScheule RK; Higgins T; Griesenbach U; Alton EWFW. SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS. Winter Meeting of the British-Thoracic-Society, 7 Dec 2011 - 9 Dec 2011. 66:A2-A2. B M J PUBLISHING GROUP (1 Dec 2011). Author weblink DOI.
  • Griesenbach U. Moving forward with cystic fibrosis gene therapy. 22:A6-A6. MARY ANN LIEBERT INC (1 Oct 2011). Author weblink.
  • Kernan NG; Cullinan P; Alton EWFW; Bilton D; Griesenbach U. ORAL CONTRACEPTIVE USE DOES NOT AFFECT CF DISEASE SEVERITY. 65:A121-A121. B M J PUBLISHING GROUP (1 Dec 2010). DOI.
  • Singh C; Munkonge FM; Smith SN; Griesenbach U; Carzaniga R; Tillmann P; Cheng S; Rogers A; et alDewar A; Alton EWFW. QUANTITATIVE BIOLOGICAL IMAGING OF PLASMID DNA IN LIVE HUMAN AIRWAY EPITHELIAL CELLS FOLLOWING NON-VIRAL GENE TRANSFER. 65:A121-A121. B M J PUBLISHING GROUP (1 Dec 2010). DOI.
  • Alton EWFW; Boyd C; Cunningham S; Davies JC; Hyde SC; Ianes JA; Gill DR; Greening A; et alGriesenbach U; Higgins T; Porteous DJ. LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS: THE RUN-IN STUDY. British-Thoracic-Society-Winter-Meeting 2010, 1 Dec 2010 - 3 Dec 2010. 65:A11-A11. B M J PUBLISHING GROUP (1 Dec 2010). DOI.
  • Innes JA; Donovan J; Soussi S; Newman N; Leiton J; Campbell K; Gibson J; Doherty A; et alAlton EWFW; Boyd C; Griesenbach U; Davies JC. INFLAMMATORY MARKERS: DATA FROM THE UK CF GENE THERAPY CONSORTIUM RUN-IN STUDY. 65:A122-A123. B M J PUBLISHING GROUP (1 Dec 2010). Author weblink DOI.
  • Griesenbach U; Roberts MJ; Vicente CC; Cheng S; Scheule R; Pringle IA; Green AM; Lawton AE; et alPlant KE; Hyde SC; Gill DR; Vrettou C; Baker A; Tennant P; McLachlan G; Collie DDS; Alton EWFW. Secreted Gaussia Luciferase Is a More Sensitive Reporter Than Firefly Luciferase for Non-Viral Gene Transfer to Airway Epithelium Ex Vivo and In Vivo. 12th Annual Meeting of the American Society of Gene Therapy, 27 May 2009 - 30 May 2009. 17:S123-S124. NATURE PUBLISHING GROUP (1 May 2009).
  • Griesenbach U; Mitomo K; Inoue M; Somerton L; Meng C; Tabata T; Ueda Y; Frankel G; et alFarley R; Singh C; Chan M; Munkonge F; Brum A; Xenariou S; Escudero-Garcia S; Hasegawa M; Alton EWFW. TOWARDS GENE THERAPY FOR CYSTIC FIBROSIS USING A LENTIVIRUS PSEUDOTYPED WITH SENDAI VIRUS ENVELOPES. Winter Meeting of the British-Thoracic-Society, 2 Dec 2009 - 4 Dec 2009. 64:A69-A70. B M J PUBLISHING GROUP (1 Dec 2009). Author weblink DOI.
  • Davies JC; Davies G; Voase N; Hyde S; Innes A; Boyd C; Porteous D; Higgins T; et alGriesenbach U; Gill D; Alton EWFW. EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''. Winter Meeting of the British-Thoracic-Society, 2 Dec 2009 - 4 Dec 2009. 64:A70-A70. B M J PUBLISHING GROUP (1 Dec 2009). DOI.
  • Griesenbach U; Vicente CC; Green A-M; Cheng SH; Scheule RK; Pringle IA; Gill DR; Hyde SC; et alAlton EWFW. Successful transfection of human air liquid interface cultures in vivo with the non-viral gene transfer agent GL67A. 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, 13 Nov 2008 - 16 Nov 2008. 19:1155-1156. MARY ANN LIEBERT INC (1 Oct 2008). Author weblink.
  • Larsen MDB; Griesenbach U; Alton EWFW. Tight junction openers increase non-viral gene transfer to the airway epithelium in vivo. 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, 13 Nov 2008 - 16 Nov 2008. 19:1125-1125. MARY ANN LIEBERT INC (1 Oct 2008). Author weblink.
  • Griesenbach U; Vicente CC; Green A-M; Cheng SH; Pringle IA; Hyde SC; Gill DR; McLachlan G; et alCollie D; Alton EW. Secreted gaussia luciferase is a sensitive reporter of gene transfer in the sheep lung. 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, 13 Nov 2008 - 16 Nov 2008. 19:1123-1123. MARY ANN LIEBERT INC (1 Oct 2008). Author weblink.
  • Mitomo K; Griesenbach U; Inoue M; Washizawa K; Fujikawa S; Iwasaki H; Somerton L; Farley R; et alSingh C; Hasegawa M; Alton E. Potential airway stem/progenitor cell integration after transduction with a lentiviral vector pseudotyped with Sendai virus envelope proteins. 5th Annual Conference of the British-Society-for-Gene-Therapy. 19:404-404. (Apr 2008).
  • Davidson H; Wilson A; Gray RD; Horsley A; Pringle I; McLachlan G; Gibson J; Holder E; et alJones L; Doherty A; Coles R; Sumner-Jones S; Wasowicz M; Manvell M; Griesenbach U; Hyde SC; Gill DR; Davies J; Collie DDS; Alton E; Porteous DJ; Boyd AC. Development of an immunocytochemical assay to detect human CFTR expression following gene therapy. 5th Annual Conference of the British-Society-for-Gene-Therapy, 7 Apr 2008 - 9 Apr 2008. 19:416-416. MARY ANN LIEBERT INC (1 Apr 2008). Author weblink.
  • Larsen MDB; Griesenbach U; Goussard S; Geddes DM; Grillot-Courvalin C; Alton E. Bactofection into airway epithelial cells in vitro and in vivo using a genetically modified Escherichia coli. Winter Meeting of the British-Thoracic-Society. 62:A105-A105. (Dec 2007).
  • Xenariou S; Griesenbach U; Liang HD; Zhu J; Farley R; Somerton L; Singh C; Jeffery PK; et alBlomley M; Alton E. Assessing ultrasound as a method to enhance non-viral gene transfer to the lung. Winter Meeting of the British-Thoracic-Society, 5 Dec 2007 - 7 Dec 2007. 62:A105-A105. B M J PUBLISHING GROUP (1 Dec 2007). Author weblink.
  • Griesenbach U; Jeswiet SB; Larsen MDB; Bakar Y; Voase NWG; Gammie FM; Mullard KE; Geddes DM; et alDavies JC; Alton EWFW; Marriott C; Gray R; Horsley A; Imrie M; Dewar M; Greening AP; Innes A. UK cf gene therapy consortium tracking study: Change in sputum properties in response to IV antibiotics. Winter Meeting of the British-Thoracic-Society, 5 Dec 2007 - 7 Dec 2007. 62:A30-A30. B M J PUBLISHING GROUP (1 Dec 2007). Author weblink.
  • Griesenbach U; Escudero-Garcia S; Farley R; Cheng S; Geddes DM; Caplen NJ; Alton E. Gene silencing through RNA interference as putative therapy for CF. Winter Meeting of the British-Thoracic-Society. 57:U83-U83. (Dec 2002).
  • Griesenbach U; Kitson C; Garcia SE; Painter H; Farley R; Chow YH; Edbrooke M; Cheng S; et alHu J; Hyde S; Geddes D; Caplen N; Alton E. Gene silencing through RNA interference and antisense strategies in the lung. 6th Annual Meeting of the American-Society-of-Gene-Therapy. 7:S389-S389. (May 2003).
  • Ban H; Inoue M; Griesenbach U; You J; Hyde SC; Alton E; Iida A; Hasegawa M. Proper maturation of CFTR protein expressed by SeV vector was proved by using a GFP-CFTR fusion protein. 7th Annual Meeting of the American-Society-of-Gene-Therapy. 9:S275-S275. (May 2004).
  • Shirohzu H; Mitomo K; Tabata T; Griesenbach U; Hyde SC; Alton EW; Ueda Y; Hasegawa M. Efficient in vivo transduction of mouse airway epithelial cells by the Simian immunodeficiency virus vector pseudotyped with Sendai virus F and HN proteins. 7th Annual Meeting of the American-Society-of-Gene-Therapy. 9:S188-S188. (May 2004).
  • Griesenbach U; Larsen MDB; Smith SN; Dewar A; Farley R; Singh C; Geddes DM; Alton E. Airway surface liquid height and nasal potential difference measurements in FABP-CF knockout mice: A core facility for screening of non-viral gene transfer agents. Winter Meeting of the British-Thoracic-Society. 59:27-27. (Dec 2004).
  • Low T; Lympany PA; Davies JC; Griesenbach U; Zheng JX; Shen N; Garcia SIE; Somerton LA; et alGeddes DM; Welsh KI; Du Bois RM; Alton E. Analysis of the effect of inflammatory gene polymorphisms on clinical phenotype in cystic fibrosis. Winter Meeting of the British-Thoracic-Society. 59:25-25. (Dec 2004).
  • Mitomo K; Griesenbach U; Inoue M; Tabata T; Geddes DM; Alton EWFW; Hasegawa M. Persistent gene expression over the life-time of airway epithelial cells transduced by lentiviral vector pseudotyped with envelope proteins F and HN from Sendai virus. 12th Annual Meeting of the Japan-Society-of-Gene-Therapy, 24 Aug 2006 - 26 Aug 2006. 8:1444-1444. JOHN WILEY & SONS LTD (1 Dec 2006). Author weblink.
  • Mitomo K; Tabata T; Inoue M; Ueda Y; Ikegami M; Fujikawa S; Washizawa K; Griesenbach U; et alAlton EWFW; Hasegawa M. Efficient transduction and prolonged gene expression in murine nasal airways mediated by simian immunodeficiency virus vectors pseudotyped with Sendai virus glycoproteins F and HN. 11th Annual Meeting of the Japan-Society-of-Gene-Therapy, 28 Jul 2005 - 30 Jul 2005. 8:389-390. JOHN WILEY & SONS LTD (1 Mar 2006). Author weblink.
  • Griesenbach U; Shiraki-Iida T; Ferrari S; Gautrey HL; Hou X; Iida A; Geddes DM; Hasegawa M; et alAlton EWFW. Infection of the murine lung with non-transmissible recombinant Sendai virus expressing the secreted protein interleukin 10. Winter Meeting of the British-Thoracic-Society, 4 Dec 2002 - 6 Dec 2002. 57. BRITISH MED JOURNAL PUBL GROUP (1 Dec 2002). Author weblink.
  • Renwick L; Tate S; Painter H; Gill D; Griesenbach U; Boyd C; Emerson M; Cheng S; et alCollie D. Biological efficacy and toxicity of naked plasmid DNA and cationic liposome-DNA complexes in ovine lung. 6th Annual Meeting of the American-Society-of-Gene-Therapy, 4 Jun 2003 - 8 Jun 2003. 7:S441-S441. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 May 2003). Author weblink.
  • Griesenbach U; Darlay R; Marshall N; Dean PJ; Williams J; Zhu J; Jeffery PK; Gill D; et alGeddes DM; Alton EWFW. Optimisation of gene transfer to the murine myocardium. 6th Annual Meeting of the American-Society-of-Gene-Therapy, 4 Jun 2003 - 8 Jun 2003. 7:S53-S54. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 May 2003). Author weblink.
  • Fox E; Griesenbach U; Geddes DM; Alton EWFW. Different nuclear localisation patterns observed in airway epithelial cells after intravenous delivery of oligonucleotides. Winter Meeting of the British Thoracic-Society, 3 Dec 2003 - 5 Dec 2003. 58:26-26. B M J PUBLISHING GROUP (1 Dec 2003). Author weblink.
  • Griesenbach U; Dean P; Marshall N; Liang HD; Xenariou S; Geddes DM; Blomley MJ; Plank C; et alAlton EWFW. Magnetofection and ultrasound to increase "naked" DNA delivery to the myocardium. 7th Annual Meeting of the American-Society-of-Gene-Therapy, 2 Jun 2004 - 6 Jun 2004. 9:S358-S358. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 May 2004). Author weblink.
  • Griesenbach U; Boyton R; Somerton L; Garcia SE; Ferrari S; Owaki T; Tsugumine S; Geddes DM; et alHasegawa M; Altmann D; Alton EWFW. Tolerisation of mice to allow repeated administration of recombinant Sendai virus vector to the airways. 7th Annual Meeting of the American-Society-of-Gene-Therapy, 2 Jun 2004 - 6 Jun 2004. 9:S274-S275. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 May 2004). Author weblink.
  • Griesenbach U; Garcia SE; Kitson C; Farley R; Singh C; Painter H; Smith RL; Scheule R; et alCheng S; Edbrooke M; Hyde S; Geddes DM; Alton EWFW. Down-regulation of the epithelial sodium channel ENaC through antisense oligonucleotides. 7th Annual Meeting of the American-Society-of-Gene-Therapy, 2 Jun 2004 - 6 Jun 2004. 9:S192-S193. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 May 2004). Author weblink.
  • McLachlan G; Griesenbach U; Owaki T; Hillery L; Williams J; Zhu YF; Boyd C; Gill D; et alHasegawa M; Alton EWFW; Collie D. Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer. 7th Annual Meeting of the American-Society-of-Gene-Therapy, 2 Jun 2004 - 6 Jun 2004. 9:S188-S188. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 May 2004). Author weblink.
  • Xenariou S; Griesenbach U; Bowden R; Hillery E; Doherty A; Geddes D; Porteous D; Plank C; et alAlton E; Boyd AC. Magnetofection to enhance transfection efficiency of large genomic context vectors in vitro. 7th Annual Meeting of the American-Society-of-Gene-Therapy, 2 Jun 2004 - 6 Jun 2004. 9:S182-S182. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 May 2004). Author weblink.
  • Xenariou S; Griesenbach U; Ferrari S; Dean P; Scheule R; Cheng S; Geddes D; Plank C; et alAlton E. Magnetofection to enhance airway gene transfer. 7th Annual Meeting of the American-Society-of-Gene-Therapy, 2 Jun 2004 - 6 Jun 2004. 9:S180-S180. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 May 2004). Author weblink.
  • Radke PW; Kivela A; Vick T; Griesenbach U; Yla-Hertualla S; Alton EW. Efficacy of vascular oligonucleotide transfer using polymer-coated stents. 16th Annual Transcatheter Cardiovascular Therapeutics Symposium, 27 Sep 2004 - 1 Oct 2004. 94:27E-28E. EXCERPTA MEDICA INC (30 Sep 2004). Author weblink.
  • Griesenbach U; Darlay R; Marshall N; Dean P; Williams J; Zhu J; Jeffery P; Gill D; et alGeddes DM; Alton EW. Optimisation of adenoviral and plasmid-mediated gene transfer to the murine myocardium. 1st Annual Conference of the British-Society-for-Gene-Therapy, 28 Mar 2004 - 30 Mar 2004. 6:S22-S22. JOHN WILEY & SONS LTD (1 Sep 2004). Author weblink.
  • Griesenbach U; Kitson C; Escudero-Garcia S; Somerton L; Painter H; Farley R; Ogilvie V; Chow YH; et alEdbrooke M; Cheng S; Porteous D; Hu J; Hyde S; Geddes D; Caplen N; Alton E. LacZ siRNA and antisense DNA decrease beta-galactosidase mRNA but not protein expression in the airways of K18-lacZ transgenic mice. 1st Annual Conference of the British-Society-for-Gene-Therapy, 28 Mar 2004 - 30 Mar 2004. 6:S21-S22. JOHN WILEY & SONS LTD (1 Sep 2004). Author weblink.
  • Munkonge FM; Hillery E; Smith JWS; Hooley RP; Griesenbach U; Amin V; Ward MA; Dunn MJ; et alDean DA; Alton EWFW. Characterisation of cytosolic DNA-binding karyophilic shuttle proteins mediating plasmid DNA import into mammalian cell nuclei. 1st Annual Conference of the British-Society-for-Gene-Therapy, 28 Mar 2004 - 30 Mar 2004. 6:S8-S8. JOHN WILEY & SONS LTD (1 Sep 2004). Author weblink.
  • McLachlan G; Griesenbach U; Owaki T; Hillery L; Williams J; Tsugumine S; Boyd C; Gill D; et alHasegawa M; Alton EWFW; Collie D. Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer. Winter Meeting of the British-Thoracic-Society, 1 Dec 2004 - 3 Dec 2004. 59:25-25. B M J PUBLISHING GROUP (1 Dec 2004). Author weblink.
  • Ferrari S; Farley R; Munkonge F; Griesenbach U; Smith SN; You J; Tokusumi T; Iida A; et alWainwright B; Gray M; Wright A; Verdon B; Argent B; Geddes DM; Hasegawa M; Alton EWFW. Recombinant Sendai virus-mediated CFTR cDNA transfer. 6th Annual Meeting of the American-Society-of-Gene-Therapy, 4 Jun 2003 - 8 Jun 2003. 7:S38-S38. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 May 2003). Author weblink.
  • Ferrari S; Griesenbach U; Farley R; Munkonge F; Smith SN; Singh C; Wright A; Wainwright B; et alGray M; Geddes DM; Hasegawa M; Alton EWFW. Recombinant Sendai virus mediates CFTR gene transfer to airway epithelium both ex vivo and in vivo. Winter Meeting of the British Thoracic-Society, 3 Dec 2003 - 5 Dec 2003. 58:19-20. B M J PUBLISHING GROUP (1 Dec 2003). Author weblink.
  • Ferrari S; Griesenbach U; Farley R; Munkonge F; Smith SN; Singh C; You J; Tokusumi T; et alIida A; Wainwright B; Gray M; Wright A; Verdon B; Argent B; Geddes DM; Hasegawa M; Alton EWFW. Recombinant sendai virus mediates CFTR gene transfer to airway epithelium both in vitro and in vivo. 1st Annual Conference of the British-Society-for-Gene-Therapy, 28 Mar 2004 - 30 Mar 2004. 6:S19-S19. JOHN WILEY & SONS LTD (1 Sep 2004). Author weblink.

Patents

  • Paramyoxovirus Vector for Gene Transfer to the Cardiovascular System. Patent number: TOKUGAN 2000-339942.
  • Specific Inhibition of Gene Expression by small double-stranded RNAs. Application: PCT/US02?24226.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook